Authors
Jennifer M Grossman, Rebecca Gordon, Veena K Ranganath, Chad Deal, Liron Caplan, Weiling Chen, Jeffrey R Curtis, Daniel E Furst, Maureen McMahon, Nivedita M Patkar, Elizabeth Volkmann, Kenneth G Saag
Publication date
2010/11
Source
Arthritis care & research
Volume
62
Issue
11
Pages
1515-1526
Publisher
John Wiley & Sons, Inc.
Description
Although glucocorticoids may effectively be used in the management of many inflammatory conditions, their use is associated with significant morbidity and mortality. Osteoporosis, with resultant fractures, constitutes one of these morbid complications and is associated with significant pain and disability. A rapid decline in bone mineral density (BMD) begins within the first 3 months of glucocorticoid use and peaks at 6 months, followed by a slower,
Total citations
20112012201320142015201620172018201920202021202220232024551001261011251131046049382318147